anprodex tablets 2 mg
malaysian pharmaceutical industries sdn. bhd. - dexchlorpheniramine maleate -
celabet syrup
west-coast pharmaceutical works limited f. p. no. 17 & 16/5, meldi estate, b/s meldi mata - betamethasone usp and dexchlorpheniramine maleate - syrup - betamethasone usp 0.25 mg and dexchlorpheniramine - dexchlorpheniramine combinations
celeb tablets
betamethasone and dexchlorpheniramine - tablet - betamethasone 0.25mg and dexchlorpheniramine 2mg - dexchlorpheniramine combinations
clarimine tablets film-coated tablet
surgilinks limited p.o.box: 14461-00800 nairobi, kenya. - betamethasone and dexchlorpheniramine maleate - film-coated tablet - betamethasone bp – 0.25 mg, dexchlorpheniramine - dexchlorpheniramine combinations
velestamine tablet
eastleigh pharmaceuticals company limited eastleigh 2nd avenue, 14th street p.o box - betamethasone and dexchlorpheniramine maleate - tablet - betamethasone 0.25mg and dexchlorpheniramine - dexchlorpheniramine combinations
zolebet tablet
betamethasone and dexchlorpheniramine maleate - tablet - betamethasone 0.25mg and dexchlorpheniramine - dexchlorpheniramine combinations
polaramine repetabs 6mg tablet (extended-release)
schering-plough canada inc - dexchlorpheniramine maleate - tablet (extended-release) - 6mg - dexchlorpheniramine maleate 6mg - propylamine derivatives
polaramine tab 2mg tablet
schering-plough canada inc - dexchlorpheniramine maleate - tablet - 2mg - dexchlorpheniramine maleate 2mg - propylamine derivatives
polmon- dexchlorpheniramine maleate solution
capellon pharmaceuticals, llc - dexchlorpheniramine maleate (unii: b10yd955qw) (dexchlorpheniramine - unii:3q9q0b929n) - perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild, uncomplicated allergic skin manifestations of urticaria and angioedema amelioration of allergic reactions to blood or plasma dermographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. use in newborn or premature infants this drug should not be used in newborn or premature infants. because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. use in lower respiratory disease antihistamines should not be used to treat lower respiratory tract symptoms including asthma. antihistamines are also contraindicated in the following conditions: - hypersensitivity to dexchlorphenira
ryclora- dexchlorpheniramine maleate liquid
carwin pharmaceutical associates, llc - dexchlorpheniramine maleate (unii: b10yd955qw) (dexchlorpheniramine - unii:3q9q0b929n) - perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild, uncomplicated allergic skin manifestations of urticaria and angioedema amelioration of allergic reactions to blood or plasma dermographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. this drug should not be used in newborn or premature infants. because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. antihistamines should not be used to treat lower respiratory tract symptoms including asthma. antihistamines are also contraindicated in the following conditions: